Investing Profile

Andrew Hack


Managing Director at Bain Capital Life Sciences

baincapital.comBoston, Massachusetts
Photo of Andrew Hack, Managing Director at Bain Capital Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Bain Capital Life Sciences Managing Director
$100K - $5.0M
CompanyStageDateRound SizeTotal Raised
Series BMay 2021$140M
Co-investors: Cameron Wheeler (Deerfield Management)
Xilio Therapeutics
Series CFeb 2021$95M
Co-investors: Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Peter Dudek (MRL Ventures Fund), Nancy Hong (RiverVest), Jack Kenney (SV Health Investors)
Atea Pharmaceuticals
Series DMay 2020$220M
Series BApr 2020$120M
Co-investors: Dorothy Margolskee (Foresite Capital)
JenaValve Technology
Series DFeb 2020$50M
Co-investors: Olivier Litzka (Andera Partners), Peter Barrett (Atlas Venture)